Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity

Yutaka Kawakami, Thomas W. Klein, Catherin Newton, Julie Y. Djeu, Steven Specter, Herman Friedman

研究成果: Article

22 引用 (Scopus)

抄録

The major psychoactive marijuana component, delta-9-tetrahydrocannabinol (THC), suppressed proliferation of murine spleen cells stimulated with recombinant human interleukin 2 (IL-2) and also suppressed the appearance of the lymphokine-activated killer (LAK) cell phenomenon in IL-2-treated spleen cell preparations. Cell function was depressed in a dose-dependent manner with as little as 2.5 μg/ml THC (8μM). In addition, spleen cells previously stimulated in culture with IL-2 and then incubated with THC for 4 h prior to target cell addition, displayed suppressed cytolytic activity against both YAC-1 and EL-4 tumor targets. Killing of EL 4 cells was suppressd at lower drug doses than the killing of YAC-1 targets. These results suggest that THC can suppress several important functions of IL-2 including clonal expansion of lymphocytes, expansion of killer cell populations and stimulation of killer cell cytotoxic activity.

元の言語English
ページ(範囲)485-488
ページ数4
ジャーナルInternational Journal of Immunopharmacology
10
発行部数4
DOI
出版物ステータスPublished - 1988
外部発表Yes

Fingerprint

Lymphokine-Activated Killer Cells
Dronabinol
Interleukin-2
Lymphocytes
Spleen
Cannabis

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

これを引用

Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity. / Kawakami, Yutaka; Klein, Thomas W.; Newton, Catherin; Djeu, Julie Y.; Specter, Steven; Friedman, Herman.

:: International Journal of Immunopharmacology, 巻 10, 番号 4, 1988, p. 485-488.

研究成果: Article

Kawakami, Yutaka ; Klein, Thomas W. ; Newton, Catherin ; Djeu, Julie Y. ; Specter, Steven ; Friedman, Herman. / Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity. :: International Journal of Immunopharmacology. 1988 ; 巻 10, 番号 4. pp. 485-488.
@article{3f130e243b0b4cd3a3e5d87c02da8319,
title = "Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity",
abstract = "The major psychoactive marijuana component, delta-9-tetrahydrocannabinol (THC), suppressed proliferation of murine spleen cells stimulated with recombinant human interleukin 2 (IL-2) and also suppressed the appearance of the lymphokine-activated killer (LAK) cell phenomenon in IL-2-treated spleen cell preparations. Cell function was depressed in a dose-dependent manner with as little as 2.5 μg/ml THC (8μM). In addition, spleen cells previously stimulated in culture with IL-2 and then incubated with THC for 4 h prior to target cell addition, displayed suppressed cytolytic activity against both YAC-1 and EL-4 tumor targets. Killing of EL 4 cells was suppressd at lower drug doses than the killing of YAC-1 targets. These results suggest that THC can suppress several important functions of IL-2 including clonal expansion of lymphocytes, expansion of killer cell populations and stimulation of killer cell cytotoxic activity.",
author = "Yutaka Kawakami and Klein, {Thomas W.} and Catherin Newton and Djeu, {Julie Y.} and Steven Specter and Herman Friedman",
year = "1988",
doi = "10.1016/0192-0561(88)90137-3",
language = "English",
volume = "10",
pages = "485--488",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity

AU - Kawakami, Yutaka

AU - Klein, Thomas W.

AU - Newton, Catherin

AU - Djeu, Julie Y.

AU - Specter, Steven

AU - Friedman, Herman

PY - 1988

Y1 - 1988

N2 - The major psychoactive marijuana component, delta-9-tetrahydrocannabinol (THC), suppressed proliferation of murine spleen cells stimulated with recombinant human interleukin 2 (IL-2) and also suppressed the appearance of the lymphokine-activated killer (LAK) cell phenomenon in IL-2-treated spleen cell preparations. Cell function was depressed in a dose-dependent manner with as little as 2.5 μg/ml THC (8μM). In addition, spleen cells previously stimulated in culture with IL-2 and then incubated with THC for 4 h prior to target cell addition, displayed suppressed cytolytic activity against both YAC-1 and EL-4 tumor targets. Killing of EL 4 cells was suppressd at lower drug doses than the killing of YAC-1 targets. These results suggest that THC can suppress several important functions of IL-2 including clonal expansion of lymphocytes, expansion of killer cell populations and stimulation of killer cell cytotoxic activity.

AB - The major psychoactive marijuana component, delta-9-tetrahydrocannabinol (THC), suppressed proliferation of murine spleen cells stimulated with recombinant human interleukin 2 (IL-2) and also suppressed the appearance of the lymphokine-activated killer (LAK) cell phenomenon in IL-2-treated spleen cell preparations. Cell function was depressed in a dose-dependent manner with as little as 2.5 μg/ml THC (8μM). In addition, spleen cells previously stimulated in culture with IL-2 and then incubated with THC for 4 h prior to target cell addition, displayed suppressed cytolytic activity against both YAC-1 and EL-4 tumor targets. Killing of EL 4 cells was suppressd at lower drug doses than the killing of YAC-1 targets. These results suggest that THC can suppress several important functions of IL-2 including clonal expansion of lymphocytes, expansion of killer cell populations and stimulation of killer cell cytotoxic activity.

UR - http://www.scopus.com/inward/record.url?scp=0023694242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023694242&partnerID=8YFLogxK

U2 - 10.1016/0192-0561(88)90137-3

DO - 10.1016/0192-0561(88)90137-3

M3 - Article

C2 - 2844686

AN - SCOPUS:0023694242

VL - 10

SP - 485

EP - 488

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 4

ER -